Great West Life Assurance Co. Can bought a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 104,896 shares of the company’s stock, valued at approximately $3,299,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Victory Capital Management Inc. raised its stake in shares of Option Care Health by 2,435.1% during the second quarter. Victory Capital Management Inc. now owns 1,274,994 shares of the company’s stock valued at $35,432,000 after acquiring an additional 1,224,700 shares in the last quarter. HMS Capital Management LLC bought a new stake in shares of Option Care Health during the third quarter valued at approximately $437,000. Coliseum Capital Management LLC bought a new stake in shares of Option Care Health during the second quarter valued at approximately $10,840,000. Jag Capital Management LLC bought a new stake in shares of Option Care Health during the second quarter valued at approximately $243,000. Finally, James Investment Research Inc. bought a new stake in shares of Option Care Health during the second quarter valued at approximately $182,000. Institutional investors own 97.63% of the company’s stock.
Analysts Set New Price Targets
Separately, Barrington Research lifted their price target on shares of Option Care Health from $37.00 to $38.00 and gave the company an “outperform” rating in a research note on Friday, October 28th.
Option Care Health Stock Performance
Option Care Health (NASDAQ:OPCH – Get Rating) last issued its quarterly earnings data on Thursday, October 27th. The company reported $0.21 EPS for the quarter, hitting analysts’ consensus estimates of $0.21. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $994.38 million. Option Care Health had a net margin of 4.64% and a return on equity of 11.80%. On average, sell-side analysts predict that Option Care Health, Inc. will post 0.79 earnings per share for the current fiscal year.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- When Will Crane Holdings Take Flight?
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Get Rating).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.